Fig. 6.
(A) Immunophenotype of BM specimen at day 42 showing high engraftment of predominantly myeloid cells with lower levels of CD3 and CD19 cells. (B) Immunophenotype of spleen cells from the same mouse showing virtually exclusive T-cell engraftment.